MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
Industry Viewpoints: Clinical Trials in Asia – Key Considerations
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations...
How to Enable Greater Budget Forecasting
Ken Olovich, R.Ph., MBA, Sourcing and Financial Director of Chorus, Eli Lilly, explains a model...
Poor Communication Can Cost You – REALLY Cost You
Daria Wicks, Director, Clinical Operations, Vericel Corporation, emphasizes the importance of clear communication within an...
To Outsource or Not to Outsource? That is the Question
Lisa Henry, Manager of Clinical Research, Cordis, discusses the merits of clinical trial outsourcing models
Execution: A Key Success Factor in All Sponsor-CRO Collaborations
Ken Getz, Tufts CSDD, examines why the sponsor-CRO dynamic often falls short of expectations
The Stem Cell Emperor’s New Clothes
James L. Sherley, M.D., Ph.D., Founder and Director, Asymmetrex, exposes a problem in the global...
Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena
Throughout this week, CTA will spotlight the ever-changing outsourcing landscape
Patient Recruitment and Retention Considerations for Clinical Trials in Latin America
Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient...
How to Manage Specialist Site Payment Providers
Jeff Nelson, VP Program Management, Mateon Therapeutics, explores the rise of specialist payment providers